Evaluating the effectiveness of zolmitriptan nasal spray in adolescents with migraines

Migraines are a type of neurological disorder that affects millions of individuals in the United States. The exact cause is unknown but results in symptoms such as moderate-severe pain, nausea, vomiting, and sensitivity to light or sound. This study is evaluating the effectiveness of different strengths of zolmitriptan nasal spray in treating migraine headaches in adolescents

Medication Under Study:

Full study title:
A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents

IRB Study ID:

Who may qualify:

Adolescents ages 12-17 with a history of migraine headaches

Who does not qualify:

Adolescents with certain medical conditions, such as those diagnosed with other headache types or those enrolled in other clinical trials

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-5012

For urgent patient care matters involving a current study patient, please call: 330-920-5774

Lead Principal Investigator:

M. Cristina Victorio, MD
Director, Headache Program; Pediatric Neurologist

Bookmark and Share

iGrow iGrow
Sign up for our parent enewsletter
    Contact Us



    find a location
    Find a location Type the first 3-5 letters of a specialty, service or location:
    Or, view: a map, a list of all locations, locations by city or locations near me.
    find a doctor
    Find a doctor Type the first 3-5 letters of the name, location or specialty:
    Or, view a list of all doctors by name, location and specialty.